Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
8-K Apr 22, 2026 8-K
CORRESP Apr 21, 2026
S-3/A Apr 21, 2026 S-3/A
8-K Apr 7, 2026 8-K
8-K Apr 7, 2026 8-K
ARS Mar 23, 2026 ARS
DEF 14A Mar 23, 2026 DEF 14A
4 Mar 18, 2026 FORM 4
4 Mar 18, 2026 FORM 4
4 Mar 18, 2026 FORM 4
4 Mar 18, 2026 FORM 4
UPLOAD Mar 17, 2026
144 Mar 16, 2026
S-3 Mar 13, 2026 S-3
PRE 14A Mar 12, 2026 PRE 14A
10-K Mar 12, 2026 10-K
8-K Mar 10, 2026 8-K
8-K Feb 19, 2026 8-K
← Newer Page 4 of 43 · 1075 filings Older →